Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $FLGT vs $NRC | Chartloom

Compare

$FLGT vs $NRC

Fulgent Genetics Inc · National Research Corp

FLGT

Fulgent Genetics Inc

NRC

National Research Corp

Compare $FLGT vs $NRC

Comparing Fulgent Genetics Inc and National Research Corp

FLGTFulgent Genetics Inc

NRCNational Research Corp

FLGTFulgent Genetics Inc

Market cap

$597M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.62x

Rev growth (TTM)

6.8%

YTD performance

-17.9%

52W performance

-6.6%

FCF yield

-17.4%

NRCNational Research Corp

Market cap

$452M

P/E (TTM)

81.00x

Forward P/E (NTM)

21.29x

Forward P/S (NTM)

3.04x

Rev growth (TTM)

-0.2%

YTD performance

13.3%

52W performance

78.0%

FCF yield

4.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FLGT

NRC

Detailed metrics comparison

FLGT

Fulgent Genetics Inc

NRC

National Research Corp

Market Cap

FLGT$597M

NRC$452M

Enterprise Value

FLGT$574M

NRC$539M

Price

FLGT$21.01

NRC$20.43

P/E Ratio

FLGTN/A

NRC81.00x

P/S Ratio

FLGT1.84x

NRC3.23x

EV/Sales

FLGT1.77x

NRC3.85x

EV/EBITDA

FLGT3.11x

NRC23.06x

P/B Ratio

FLGT0.60x

NRC68.67x

P/FCF Ratio

FLGTN/A

NRC20.90x

EV/FCF

FLGT-5.53x

NRC24.91x

PEG Ratio

FLGTN/A

NRCN/A

Forward P/E (NTM)

FLGTN/A

NRC21.29x

Forward P/S (NTM)

FLGT1.62x

NRC3.04x

Revenue (TTM)

FLGT$324M

NRC$140M

Revenue Growth (YoY)

FLGT6.8%

NRC-0.2%

Forward Rev Growth

FLGT15.4%

NRC8.3%

Gross Margin (TTM)

FLGT35.6%

NRC61.7%

Operating Margin (TTM)

FLGT0.0%

NRC10.5%

EBITDA Margin (TTM)

FLGT-29.1%

NRC16.7%

Net Margin (TTM)

FLGT-26.0%

NRC4.0%

FCF Margin (TTM)

FLGT-32.0%

NRC15.5%

Net Income (TTM)

FLGT$-84M

NRC$6M

FCF (TTM)

FLGT$-104M

NRC$22M

EPS (TTM)

FLGT-$3.01

NRC$0.25

ROE (TTM)

FLGT-787.0%

NRC48.5%

ROA (TTM)

FLGT-722.0%

NRC4.3%

ROIC (TTM)

FLGT-785.0%

NRC6.2%

Cash

FLGT$26M

NRC$3M

Debt

FLGT$4M

NRC$90M

Net Cash/Debt

FLGT$22M

NRC$-87M

Current Ratio (TTM)

FLGT6.34x

NRC0.65x

Quick Ratio (TTM)

FLGT4.72x

NRC0.50x

Debt/Equity (TTM)

FLGT0.00x

NRC13.75x

Debt/Assets (TTM)

FLGT0.0%

NRC0.0%

Interest Coverage (TTM)

FLGTN/A

NRCN/A

Net Debt/EBITDA (TTM)

FLGT0.00x

NRC0.00x

Beta

FLGT1.03

NRC0.26

52W Performance

FLGT-6.6%

NRC78.0%

YTD Performance

FLGT-17.9%

NRC13.3%

% from 52W High

FLGT-32.3%

NRC-13.7%

% from 52W Low

FLGT56.1%

NRC85.5%

Asset Turnover (TTM)

FLGT0.28x

NRC1.03x

FCF Yield (TTM)

FLGT-17.4%

NRC4.8%

Earnings Yield (TTM)

FLGT-14.1%

NRC1.2%

Dividend Yield (TTM)

FLGTN/A

NRC2.8%

Rule of 40

FLGT-25.2

NRC15.2

EV/GP/RG

FLGT0.03

NRC0.98

Ticker research

View FLGT research View NRC research

Metric	FLGT Fulgent Genetics Inc	NRC National Research Corp
Market & Valuation
Market Cap	$597M	$452M
Enterprise Value	$574M	$539M
Price	$21.01	$20.43
P/E Ratio	N/A	81.00x
P/S Ratio	1.84x	3.23x
EV/Sales	1.77x	3.85x
EV/EBITDA	3.11x	23.06x
P/B Ratio	0.60x	68.67x
P/FCF Ratio	N/A	20.90x
EV/FCF	-5.53x	24.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	21.29x
Forward P/S (NTM)	1.62x	3.04x
Revenue & Growth
Revenue (TTM)	$324M	$140M
Revenue Growth (YoY)	6.8%	-0.2%
Forward Rev Growth	15.4%	8.3%
Profitability
Gross Margin (TTM)	35.6%	61.7%
Operating Margin (TTM)	0.0%	10.5%
EBITDA Margin (TTM)	-29.1%	16.7%
Net Margin (TTM)	-26.0%	4.0%
FCF Margin (TTM)	-32.0%	15.5%
Net Income (TTM)	$-84M	$6M
FCF (TTM)	$-104M	$22M
EPS (TTM)	-$3.01	$0.25
ROE (TTM)	-787.0%	48.5%
ROA (TTM)	-722.0%	4.3%
ROIC (TTM)	-785.0%	6.2%
Financial Health
Cash	$26M	$3M
Debt	$4M	$90M
Net Cash/Debt	$22M	$-87M
Current Ratio (TTM)	6.34x	0.65x
Quick Ratio (TTM)	4.72x	0.50x
Debt/Equity (TTM)	0.00x	13.75x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.03	0.26
52W Performance	-6.6%	78.0%
YTD Performance	-17.9%	13.3%
% from 52W High	-32.3%	-13.7%
% from 52W Low	56.1%	85.5%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	1.03x
FCF Yield (TTM)	-17.4%	4.8%
Earnings Yield (TTM)	-14.1%	1.2%
Dividend Yield (TTM)	N/A	2.8%
Other
Rule of 40	-25.2	15.2
EV/GP/RG	0.03	0.98
Ticker research	View FLGT research	View NRC research

Valuation

P/E Ratio

NRC

81.00x

P/S Ratio

FLGT

1.84x

NRC

3.23x

EV/FCF

FLGT

-5.53x

NRC

24.91x

Growth & revenue

Revenue Growth TTM

FLGT

6.8%

NRC

-0.2%

Forward Revenue Growth

FLGT

15.4%

NRC

8.3%

Profitability & performance

Gross Margin

NRC

61.7%

FLGT

35.6%

ROE

NRC

48.5%

FLGT

-787.0%

FCF Yield %

NRC

4.8%

FLGT

-17.4%

52-Week Performance

NRC

78.0%

FLGT

-6.6%

Detailed metrics comparison

FLGT

Fulgent Genetics Inc

NRC

National Research Corp

Market Cap

FLGT$597M

NRC$452M

Enterprise Value

FLGT$574M

NRC$539M

Price

FLGT$21.01

NRC$20.43

P/E Ratio

FLGTN/A

NRC81.00x

P/S Ratio

FLGT1.84x

NRC3.23x

EV/Sales

FLGT1.77x

NRC3.85x

EV/EBITDA

FLGT3.11x

NRC23.06x

P/B Ratio

FLGT0.60x

NRC68.67x

P/FCF Ratio

FLGTN/A

NRC20.90x

EV/FCF

FLGT-5.53x

NRC24.91x

PEG Ratio

FLGTN/A

NRCN/A

Forward P/E (NTM)

FLGTN/A

NRC21.29x

Forward P/S (NTM)

FLGT1.62x

NRC3.04x

Revenue (TTM)

FLGT$324M

NRC$140M

Revenue Growth (YoY)

FLGT6.8%

NRC-0.2%

Forward Rev Growth

FLGT15.4%

NRC8.3%

Gross Margin (TTM)

FLGT35.6%

NRC61.7%

Operating Margin (TTM)

FLGT0.0%

NRC10.5%

EBITDA Margin (TTM)

FLGT-29.1%

NRC16.7%

Net Margin (TTM)

FLGT-26.0%

NRC4.0%

FCF Margin (TTM)

FLGT-32.0%

NRC15.5%

Net Income (TTM)

FLGT$-84M

NRC$6M

FCF (TTM)

FLGT$-104M

NRC$22M

EPS (TTM)

FLGT-$3.01

NRC$0.25

ROE (TTM)

FLGT-787.0%

NRC48.5%

ROA (TTM)

FLGT-722.0%

NRC4.3%

ROIC (TTM)

FLGT-785.0%

NRC6.2%

Cash

FLGT$26M

NRC$3M

Debt

FLGT$4M

NRC$90M

Net Cash/Debt

FLGT$22M

NRC$-87M

Current Ratio (TTM)

FLGT6.34x

NRC0.65x

Quick Ratio (TTM)

FLGT4.72x

NRC0.50x

Debt/Equity (TTM)

FLGT0.00x

NRC13.75x

Debt/Assets (TTM)

FLGT0.0%

NRC0.0%

Interest Coverage (TTM)

FLGTN/A

NRCN/A

Net Debt/EBITDA (TTM)

FLGT0.00x

NRC0.00x

Beta

FLGT1.03

NRC0.26

52W Performance

FLGT-6.6%

NRC78.0%

YTD Performance

FLGT-17.9%

NRC13.3%

% from 52W High

FLGT-32.3%

NRC-13.7%

% from 52W Low

FLGT56.1%

NRC85.5%

Asset Turnover (TTM)

FLGT0.28x

NRC1.03x

FCF Yield (TTM)

FLGT-17.4%

NRC4.8%

Earnings Yield (TTM)

FLGT-14.1%

NRC1.2%

Dividend Yield (TTM)

FLGTN/A

NRC2.8%

Rule of 40

FLGT-25.2

NRC15.2

EV/GP/RG

FLGT0.03

NRC0.98

Ticker research

View FLGT research View NRC research

Metric	FLGT Fulgent Genetics Inc	NRC National Research Corp
Market & Valuation
Market Cap	$597M	$452M
Enterprise Value	$574M	$539M
Price	$21.01	$20.43
P/E Ratio	N/A	81.00x
P/S Ratio	1.84x	3.23x
EV/Sales	1.77x	3.85x
EV/EBITDA	3.11x	23.06x
P/B Ratio	0.60x	68.67x
P/FCF Ratio	N/A	20.90x
EV/FCF	-5.53x	24.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	21.29x
Forward P/S (NTM)	1.62x	3.04x
Revenue & Growth
Revenue (TTM)	$324M	$140M
Revenue Growth (YoY)	6.8%	-0.2%
Forward Rev Growth	15.4%	8.3%
Profitability
Gross Margin (TTM)	35.6%	61.7%
Operating Margin (TTM)	0.0%	10.5%
EBITDA Margin (TTM)	-29.1%	16.7%
Net Margin (TTM)	-26.0%	4.0%
FCF Margin (TTM)	-32.0%	15.5%
Net Income (TTM)	$-84M	$6M
FCF (TTM)	$-104M	$22M
EPS (TTM)	-$3.01	$0.25
ROE (TTM)	-787.0%	48.5%
ROA (TTM)	-722.0%	4.3%
ROIC (TTM)	-785.0%	6.2%
Financial Health
Cash	$26M	$3M
Debt	$4M	$90M
Net Cash/Debt	$22M	$-87M
Current Ratio (TTM)	6.34x	0.65x
Quick Ratio (TTM)	4.72x	0.50x
Debt/Equity (TTM)	0.00x	13.75x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.03	0.26
52W Performance	-6.6%	78.0%
YTD Performance	-17.9%	13.3%
% from 52W High	-32.3%	-13.7%
% from 52W Low	56.1%	85.5%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	1.03x
FCF Yield (TTM)	-17.4%	4.8%
Earnings Yield (TTM)	-14.1%	1.2%
Dividend Yield (TTM)	N/A	2.8%
Other
Rule of 40	-25.2	15.2
EV/GP/RG	0.03	0.98
Ticker research	View FLGT research	View NRC research